Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Clinical trial NCT03841747 · WITHDRAWN
Trial details
- NCT number
- NCT03841747
- Sponsor
- Queen Mary University of London
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.